

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.03206080 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.91152687 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.91152687 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 5.91152687 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.91152687 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.91152687 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.91152687 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.48303002 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.48303002 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.36766100 |
| 11 | respiratory burst (GO:0045730) | 5.02782481 |
| 12 | response to peptidoglycan (GO:0032494) | 4.86326783 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.71247389 |
| 14 | cellular extravasation (GO:0045123) | 4.63622922 |
| 15 | granulocyte activation (GO:0036230) | 4.50286671 |
| 16 | superoxide anion generation (GO:0042554) | 4.49794458 |
| 17 | neutrophil activation (GO:0042119) | 4.48183731 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.45525194 |
| 19 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.44664096 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.40471950 |
| 21 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.37047996 |
| 22 | response to host immune response (GO:0052572) | 4.35679031 |
| 23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.35679031 |
| 24 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.29083298 |
| 25 | positive regulation of interferon-alpha production (GO:0032727) | 4.22974281 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 4.10452152 |
| 27 | detection of biotic stimulus (GO:0009595) | 4.09064917 |
| 28 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.02697965 |
| 29 | positive regulation of mast cell degranulation (GO:0043306) | 4.02697965 |
| 30 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.99695371 |
| 31 | regulation of interferon-alpha production (GO:0032647) | 3.97597644 |
| 32 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.93464966 |
| 33 | response to host (GO:0075136) | 3.93464966 |
| 34 | response to host defenses (GO:0052200) | 3.93464966 |
| 35 | reactive oxygen species biosynthetic process (GO:1903409) | 3.91803371 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 3.86658959 |
| 37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.86388333 |
| 38 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.85830850 |
| 39 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.85563816 |
| 40 | regulation of mast cell degranulation (GO:0043304) | 3.81662249 |
| 41 | positive regulation of mast cell activation (GO:0033005) | 3.75845636 |
| 42 | leukocyte aggregation (GO:0070486) | 3.71282534 |
| 43 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.63679974 |
| 44 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.58983419 |
| 45 | myeloid cell activation involved in immune response (GO:0002275) | 3.56277619 |
| 46 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.55818496 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.44981138 |
| 48 | negative regulation of T cell mediated immunity (GO:0002710) | 3.43540736 |
| 49 | myeloid leukocyte mediated immunity (GO:0002444) | 3.42706793 |
| 50 | leukocyte degranulation (GO:0043299) | 3.42212055 |
| 51 | regulation of mast cell activation (GO:0033003) | 3.39211224 |
| 52 | detection of molecule of bacterial origin (GO:0032490) | 3.37898907 |
| 53 | response to type I interferon (GO:0034340) | 3.37392241 |
| 54 | type I interferon signaling pathway (GO:0060337) | 3.36568307 |
| 55 | cellular response to type I interferon (GO:0071357) | 3.36568307 |
| 56 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.36208690 |
| 57 | detection of other organism (GO:0098543) | 3.34635317 |
| 58 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.33308297 |
| 59 | macrophage activation (GO:0042116) | 3.32248634 |
| 60 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.31066909 |
| 61 | microglial cell activation (GO:0001774) | 3.30344604 |
| 62 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.29157225 |
| 63 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.27472409 |
| 64 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.26687820 |
| 65 | regulation of leukocyte degranulation (GO:0043300) | 3.24078547 |
| 66 | response to muramyl dipeptide (GO:0032495) | 3.23004967 |
| 67 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.21839953 |
| 68 | positive regulation of B cell differentiation (GO:0045579) | 3.20815881 |
| 69 | positive regulation of leukocyte degranulation (GO:0043302) | 3.18562427 |
| 70 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.18493083 |
| 71 | negative regulation of interleukin-6 production (GO:0032715) | 3.17167666 |
| 72 | lymphocyte chemotaxis (GO:0048247) | 3.16394135 |
| 73 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.14712865 |
| 74 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.14147986 |
| 75 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.14054015 |
| 76 | T cell migration (GO:0072678) | 3.13748328 |
| 77 | neutrophil chemotaxis (GO:0030593) | 3.11894205 |
| 78 | histamine secretion (GO:0001821) | 3.10849560 |
| 79 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.10184873 |
| 80 | negative regulation of interleukin-1 production (GO:0032692) | 3.10147245 |
| 81 | regulation of B cell differentiation (GO:0045577) | 3.09199960 |
| 82 | response to interleukin-15 (GO:0070672) | 3.08651958 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.07944447 |
| 84 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.07944447 |
| 85 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.07877392 |
| 86 | defense response to protozoan (GO:0042832) | 3.07853445 |
| 87 | positive regulation of interferon-beta production (GO:0032728) | 3.07664457 |
| 88 | positive regulation of antigen processing and presentation (GO:0002579) | 3.06184328 |
| 89 | T-helper 1 type immune response (GO:0042088) | 3.05409702 |
| 90 | neutrophil migration (GO:1990266) | 3.05000561 |
| 91 | regulation of antigen processing and presentation (GO:0002577) | 3.04992913 |
| 92 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.04979683 |
| 93 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.03795429 |
| 94 | negative regulation of phagocytosis (GO:0050765) | 3.03235627 |
| 95 | B cell receptor signaling pathway (GO:0050853) | 3.02135906 |
| 96 | regulation of tolerance induction (GO:0002643) | 3.01314598 |
| 97 | detection of external biotic stimulus (GO:0098581) | 2.99869031 |
| 98 | regulation of regulated secretory pathway (GO:1903305) | 2.98374151 |
| 99 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97297523 |
| 100 | germinal center formation (GO:0002467) | 2.96875878 |
| 101 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.96817549 |
| 102 | B cell mediated immunity (GO:0019724) | 2.96504808 |
| 103 | detection of bacterium (GO:0016045) | 2.94776848 |
| 104 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.94678958 |
| 105 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.94170905 |
| 106 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.93891833 |
| 107 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.93005685 |
| 108 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.90542243 |
| 109 | leukotriene metabolic process (GO:0006691) | 2.89702142 |
| 110 | myeloid leukocyte activation (GO:0002274) | 2.89560233 |
| 111 | myeloid dendritic cell differentiation (GO:0043011) | 2.89307904 |
| 112 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.89246159 |
| 113 | regulation of mononuclear cell migration (GO:0071675) | 2.88834910 |
| 114 | negative regulation of interleukin-12 production (GO:0032695) | 2.87970396 |
| 115 | leukocyte cell-cell adhesion (GO:0007159) | 2.87634905 |
| 116 | regulation of T cell tolerance induction (GO:0002664) | 2.87582959 |
| 117 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.86902685 |
| 118 | leukocyte mediated cytotoxicity (GO:0001909) | 2.84899688 |
| 119 | neutrophil mediated immunity (GO:0002446) | 2.84038831 |
| 120 | negative regulation of innate immune response (GO:0045824) | 2.82746393 |
| 121 | dendritic cell chemotaxis (GO:0002407) | 2.82039422 |
| 122 | positive regulation of type 2 immune response (GO:0002830) | 2.81773800 |
| 123 | negative regulation of viral genome replication (GO:0045071) | 2.81189738 |
| 124 | response to interferon-alpha (GO:0035455) | 2.81157748 |
| 125 | myeloid dendritic cell activation (GO:0001773) | 2.80758203 |
| 126 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.79338813 |
| 127 | regulation of monocyte chemotaxis (GO:0090025) | 2.78729013 |
| 128 | response to protozoan (GO:0001562) | 2.78518841 |
| 129 | cytokine secretion (GO:0050663) | 2.78370439 |
| 130 | dendritic cell migration (GO:0036336) | 2.76944367 |
| 131 | response to fungus (GO:0009620) | 2.76889766 |
| 132 | granulocyte chemotaxis (GO:0071621) | 2.76649774 |
| 133 | positive regulation of lymphocyte migration (GO:2000403) | 2.73463997 |
| 134 | granulocyte migration (GO:0097530) | 2.72601401 |
| 135 | regulation of integrin activation (GO:0033623) | 2.71977442 |
| 136 | negative regulation of mast cell activation (GO:0033004) | 2.71728375 |
| 137 | lipoxygenase pathway (GO:0019372) | 2.70954185 |
| 138 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.70839840 |
| 139 | natural killer cell mediated immunity (GO:0002228) | 2.70839840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.11846964 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.57920317 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.74622405 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.27330676 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.08487367 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.88156646 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.64168514 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.54622783 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.43504164 |
| 10 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.41627728 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.25384955 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.19104883 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.94227102 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.90750726 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.90180885 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.89724281 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.69512113 |
| 18 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43828227 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.40612308 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.34654650 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.16195834 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.05788925 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.93989352 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.93710306 |
| 25 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.88302790 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.82959045 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79851585 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.78159350 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.71173169 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.69937914 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68914594 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.68498961 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67933969 |
| 34 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.66636086 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65378433 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.63473971 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59892494 |
| 38 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58301377 |
| 39 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53212331 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53036059 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52895572 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49733335 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.49159775 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.46131230 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.39228980 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.35825757 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35385228 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.29564720 |
| 49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29424220 |
| 50 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29280976 |
| 51 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.29049889 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26347682 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26024816 |
| 54 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25789390 |
| 55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24209239 |
| 56 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23808504 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.21966205 |
| 58 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21195617 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20857016 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19823336 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19507346 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17566636 |
| 63 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.12127672 |
| 64 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.12031070 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11412518 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11323988 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10253640 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10111945 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09623457 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09144324 |
| 71 | MYC_22102868_ChIP-Seq_BL_Human | 1.08909218 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08591953 |
| 73 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.08509115 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08195670 |
| 75 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05045821 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04780803 |
| 77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04606978 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03711697 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02866518 |
| 80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01508141 |
| 81 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00402310 |
| 82 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98833070 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98395036 |
| 84 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.98240208 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98024163 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96488255 |
| 87 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96175290 |
| 88 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95159945 |
| 89 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94786406 |
| 90 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94089831 |
| 91 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93984069 |
| 92 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93924313 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92568069 |
| 94 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92499447 |
| 95 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92315423 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90834227 |
| 97 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90199560 |
| 98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88064433 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87247008 |
| 100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86463233 |
| 101 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.84365469 |
| 102 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84156876 |
| 103 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84156876 |
| 104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83691235 |
| 105 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83606072 |
| 106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82606859 |
| 107 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82555821 |
| 108 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80877606 |
| 109 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78369506 |
| 110 | GATA1_22025678_ChIP-Seq_K562_Human | 0.76509243 |
| 111 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75288006 |
| 112 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74668369 |
| 113 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.73969046 |
| 114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73967421 |
| 115 | P300_27268052_Chip-Seq_Bcells_Human | 0.73228992 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72833453 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72669317 |
| 118 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72494885 |
| 119 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72354547 |
| 120 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72268808 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.70909147 |
| 122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.70444227 |
| 123 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.70139157 |
| 124 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69979553 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69979553 |
| 126 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.68368416 |
| 127 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.67778747 |
| 128 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.67439778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.34476329 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.02719670 |
| 3 | MP0009785_altered_susceptibility_to | 3.86478750 |
| 4 | MP0003724_increased_susceptibility_to | 3.74206695 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.53403080 |
| 6 | MP0003303_peritoneal_inflammation | 3.52085584 |
| 7 | MP0002419_abnormal_innate_immunity | 3.32203877 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.15306745 |
| 9 | MP0005025_abnormal_response_to | 3.05739084 |
| 10 | MP0006082_CNS_inflammation | 2.88897320 |
| 11 | MP0005387_immune_system_phenotype | 2.81659522 |
| 12 | MP0001790_abnormal_immune_system | 2.81659522 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.71299916 |
| 14 | * MP0001800_abnormal_humoral_immune | 2.53431464 |
| 15 | * MP0002723_abnormal_immune_serum | 2.45457793 |
| 16 | MP0000685_abnormal_immune_system | 2.45234076 |
| 17 | MP0001533_abnormal_skeleton_physiology | 2.37831288 |
| 18 | * MP0001819_abnormal_immune_cell | 2.29425499 |
| 19 | MP0009278_abnormal_bone_marrow | 2.27608554 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.27100891 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.15523076 |
| 22 | MP0004947_skin_inflammation | 2.14334381 |
| 23 | MP0005671_abnormal_response_to | 2.04428702 |
| 24 | MP0005058_abnormal_lysosome_morphology | 2.03052774 |
| 25 | MP0002405_respiratory_system_inflammati | 2.01066603 |
| 26 | MP0009764_decreased_sensitivity_to | 1.95933777 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.93843773 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.91008059 |
| 29 | MP0009840_abnormal_foam_cell | 1.89011857 |
| 30 | MP0004510_myositis | 1.86510537 |
| 31 | MP0000343_altered_response_to | 1.82883290 |
| 32 | MP0003075_altered_response_to | 1.80743624 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.77287770 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.74702486 |
| 35 | MP0003448_altered_tumor_morphology | 1.74034286 |
| 36 | MP0002132_abnormal_respiratory_system | 1.73240470 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.67807708 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.64286200 |
| 39 | MP0001853_heart_inflammation | 1.63619432 |
| 40 | * MP0000716_abnormal_immune_system | 1.61158788 |
| 41 | MP0008469_abnormal_protein_level | 1.60248743 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.56844323 |
| 43 | MP0005166_decreased_susceptibility_to | 1.54307014 |
| 44 | * MP0002398_abnormal_bone_marrow | 1.45655480 |
| 45 | MP0002006_tumorigenesis | 1.39057714 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.38466806 |
| 47 | MP0005310_abnormal_salivary_gland | 1.37115099 |
| 48 | MP0000858_altered_metastatic_potential | 1.35972925 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.34854006 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.34188164 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.34188164 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.32371485 |
| 53 | * MP0002429_abnormal_blood_cell | 1.28609813 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.28581875 |
| 55 | MP0001851_eye_inflammation | 1.27140781 |
| 56 | MP0003828_pulmonary_edema | 1.26443604 |
| 57 | MP0005164_abnormal_response_to | 1.21424314 |
| 58 | MP0005390_skeleton_phenotype | 1.17986117 |
| 59 | MP0003806_abnormal_nucleotide_metabolis | 1.17699247 |
| 60 | MP0002722_abnormal_immune_system | 1.14134695 |
| 61 | MP0002933_joint_inflammation | 1.13462970 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.10203772 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.09604096 |
| 64 | MP0002166_altered_tumor_susceptibility | 1.09525401 |
| 65 | MP0002396_abnormal_hematopoietic_system | 1.05901819 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.05493134 |
| 67 | MP0005174_abnormal_tail_pigmentation | 1.04518258 |
| 68 | MP0008004_abnormal_stomach_pH | 1.00560133 |
| 69 | MP0000703_abnormal_thymus_morphology | 0.99803457 |
| 70 | MP0006054_spinal_hemorrhage | 0.98144833 |
| 71 | MP0004883_abnormal_blood_vessel | 0.96703763 |
| 72 | MP0000249_abnormal_blood_vessel | 0.95820457 |
| 73 | MP0001986_abnormal_taste_sensitivity | 0.95225968 |
| 74 | MP0000490_abnormal_crypts_of | 0.93824110 |
| 75 | MP0000604_amyloidosis | 0.91611584 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 0.91469415 |
| 77 | MP0001873_stomach_inflammation | 0.91289546 |
| 78 | MP0003690_abnormal_glial_cell | 0.90329693 |
| 79 | MP0005076_abnormal_cell_differentiation | 0.88561354 |
| 80 | MP0004808_abnormal_hematopoietic_stem | 0.88486927 |
| 81 | MP0001663_abnormal_digestive_system | 0.88396299 |
| 82 | MP0010352_gastrointestinal_tract_polyps | 0.88293925 |
| 83 | MP0003866_abnormal_defecation | 0.87772589 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.86930206 |
| 85 | MP0009763_increased_sensitivity_to | 0.84196718 |
| 86 | MP0002136_abnormal_kidney_physiology | 0.82990162 |
| 87 | MP0000569_abnormal_digit_pigmentation | 0.81570783 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.81423014 |
| 89 | MP0005451_abnormal_body_composition | 0.78360008 |
| 90 | MP0008260_abnormal_autophagy | 0.78302619 |
| 91 | MP0002254_reproductive_system_inflammat | 0.75052663 |
| 92 | MP0005360_urolithiasis | 0.74873294 |
| 93 | MP0004381_abnormal_hair_follicle | 0.73650079 |
| 94 | MP0001879_abnormal_lymphatic_vessel | 0.73385528 |
| 95 | MP0001542_abnormal_bone_strength | 0.73049945 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.71521539 |
| 97 | MP0003186_abnormal_redox_activity | 0.70384110 |
| 98 | MP0003091_abnormal_cell_migration | 0.69538575 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.67799734 |
| 100 | MP0010307_abnormal_tumor_latency | 0.65916252 |
| 101 | MP0005023_abnormal_wound_healing | 0.65797937 |
| 102 | MP0001958_emphysema | 0.65645455 |
| 103 | MP0005084_abnormal_gallbladder_morpholo | 0.63679950 |
| 104 | MP0002332_abnormal_exercise_endurance | 0.61501043 |
| 105 | MP0003795_abnormal_bone_structure | 0.60450105 |
| 106 | MP0003252_abnormal_bile_duct | 0.59723283 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.59253859 |
| 108 | MP0003279_aneurysm | 0.58576651 |
| 109 | MP0003045_fibrosis | 0.57936732 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.57024424 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.56898057 |
| 112 | MP0002928_abnormal_bile_duct | 0.56839550 |
| 113 | MP0008874_decreased_physiological_sensi | 0.54688707 |
| 114 | MP0001666_abnormal_nutrient_absorption | 0.53902822 |
| 115 | MP0004484_altered_response_of | 0.53747584 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.53643734 |
| 117 | MP0001216_abnormal_epidermal_layer | 0.53630415 |
| 118 | MP0003763_abnormal_thymus_physiology | 0.53367399 |
| 119 | MP0001191_abnormal_skin_condition | 0.52522688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.68020673 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.38728717 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.05761485 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.42135663 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 5.84714862 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.44071911 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.67890948 |
| 8 | Cellulitis (HP:0100658) | 4.55170076 |
| 9 | Gingivitis (HP:0000230) | 4.53522972 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.33681560 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.32456014 |
| 12 | Recurrent skin infections (HP:0001581) | 4.25873893 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 4.09421879 |
| 14 | Obstructive lung disease (HP:0006536) | 4.09421879 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 4.08635750 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.83892443 |
| 17 | Myositis (HP:0100614) | 3.80246826 |
| 18 | Interstitial pulmonary disease (HP:0006530) | 3.78292993 |
| 19 | Orchitis (HP:0100796) | 3.73402667 |
| 20 | Pustule (HP:0200039) | 3.66381582 |
| 21 | Stomatitis (HP:0010280) | 3.59487375 |
| 22 | Keratoconjunctivitis (HP:0001096) | 3.59090224 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.58694559 |
| 24 | Recurrent viral infections (HP:0004429) | 3.58018052 |
| 25 | Episodic fever (HP:0001954) | 3.43343377 |
| 26 | Peritonitis (HP:0002586) | 3.39328060 |
| 27 | Hypochromic microcytic anemia (HP:0004840) | 3.38226103 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.33990166 |
| 29 | Optic neuritis (HP:0100653) | 3.33990166 |
| 30 | Amyloidosis (HP:0011034) | 3.32034153 |
| 31 | Thick nail (HP:0001805) | 3.28788160 |
| 32 | Meningitis (HP:0001287) | 3.26085549 |
| 33 | Osteomyelitis (HP:0002754) | 3.21314786 |
| 34 | Vasculitis (HP:0002633) | 3.18791192 |
| 35 | Recurrent pneumonia (HP:0006532) | 3.17269424 |
| 36 | Chest pain (HP:0100749) | 3.13817493 |
| 37 | Spontaneous hematomas (HP:0007420) | 3.12949203 |
| 38 | Prostate neoplasm (HP:0100787) | 3.10224753 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 3.08095283 |
| 40 | Periodontitis (HP:0000704) | 3.03975561 |
| 41 | Thyroiditis (HP:0100646) | 2.98373529 |
| 42 | Axonal loss (HP:0003447) | 2.96959633 |
| 43 | Hypochromic anemia (HP:0001931) | 2.94370060 |
| 44 | Urticaria (HP:0001025) | 2.93080680 |
| 45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.85963868 |
| 46 | Sepsis (HP:0100806) | 2.83428633 |
| 47 | Autoimmune hemolytic anemia (HP:0001890) | 2.83234396 |
| 48 | Recurrent cutaneous fungal infections (HP:0011370) | 2.82055570 |
| 49 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.82055570 |
| 50 | Recurrent lower respiratory tract infections (HP:0002783) | 2.74806982 |
| 51 | Increased IgE level (HP:0003212) | 2.68168102 |
| 52 | Pulmonary embolism (HP:0002204) | 2.67098539 |
| 53 | Leukocytosis (HP:0001974) | 2.65710831 |
| 54 | Agammaglobulinemia (HP:0004432) | 2.62231510 |
| 55 | Hematochezia (HP:0002573) | 2.60020062 |
| 56 | Abnormality of the pleura (HP:0002103) | 2.59927682 |
| 57 | Eosinophilia (HP:0001880) | 2.59599046 |
| 58 | Glomerulonephritis (HP:0000099) | 2.59538181 |
| 59 | Microcytic anemia (HP:0001935) | 2.54378049 |
| 60 | T lymphocytopenia (HP:0005403) | 2.54097343 |
| 61 | Basal ganglia calcification (HP:0002135) | 2.53927227 |
| 62 | Chronic otitis media (HP:0000389) | 2.52575924 |
| 63 | Petechiae (HP:0000967) | 2.52396604 |
| 64 | Panhypogammaglobulinemia (HP:0003139) | 2.49133388 |
| 65 | Abnormality of T cells (HP:0002843) | 2.48648910 |
| 66 | Gangrene (HP:0100758) | 2.44044919 |
| 67 | Colitis (HP:0002583) | 2.43642387 |
| 68 | Disinhibition (HP:0000734) | 2.42648101 |
| 69 | Joint hemorrhage (HP:0005261) | 2.41554628 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.39277578 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 2.34670074 |
| 72 | Increased serum ferritin (HP:0003281) | 2.33887339 |
| 73 | Abnormality of the peritoneum (HP:0002585) | 2.31579792 |
| 74 | Increased IgM level (HP:0003496) | 2.29142501 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 2.26367723 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 2.24792986 |
| 77 | Abnormality of glycolipid metabolism (HP:0010969) | 2.23462108 |
| 78 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.23462108 |
| 79 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.23462108 |
| 80 | Loss of speech (HP:0002371) | 2.23105233 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.22126715 |
| 82 | Vertigo (HP:0002321) | 2.21904140 |
| 83 | Hypergammaglobulinemia (HP:0010702) | 2.21504878 |
| 84 | Nephritis (HP:0000123) | 2.20334981 |
| 85 | Cheilitis (HP:0100825) | 2.20113976 |
| 86 | Hemoptysis (HP:0002105) | 2.19156415 |
| 87 | Pulmonary infiltrates (HP:0002113) | 2.18948985 |
| 88 | Osteolytic defects of the hand bones (HP:0009699) | 2.18353957 |
| 89 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.18353957 |
| 90 | Abnormality of the pericardium (HP:0001697) | 2.17330175 |
| 91 | Polyneuropathy (HP:0001271) | 2.16947709 |
| 92 | Skin ulcer (HP:0200042) | 2.16731734 |
| 93 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.14614779 |
| 94 | Glomerulopathy (HP:0100820) | 2.13559516 |
| 95 | Combined immunodeficiency (HP:0005387) | 2.11384571 |
| 96 | Purpura (HP:0000979) | 2.10673726 |
| 97 | Granulocytopenia (HP:0001913) | 2.10325530 |
| 98 | Tetraparesis (HP:0002273) | 2.09839625 |
| 99 | Abnormality of eosinophils (HP:0001879) | 2.08863180 |
| 100 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.06778085 |
| 101 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.05164303 |
| 102 | Acne (HP:0001061) | 2.04304819 |
| 103 | Abnormality of the endocardium (HP:0004306) | 2.03755265 |
| 104 | Keratoconjunctivitis sicca (HP:0001097) | 2.03481265 |
| 105 | Severe combined immunodeficiency (HP:0004430) | 2.02735687 |
| 106 | Abnormality of the nasal mucosa (HP:0000433) | 2.02118093 |
| 107 | Arterial thrombosis (HP:0004420) | 2.00843482 |
| 108 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00375944 |
| 109 | Keratitis (HP:0000491) | 1.99685749 |
| 110 | Stomach cancer (HP:0012126) | 1.99586509 |
| 111 | Myocardial infarction (HP:0001658) | 1.98261769 |
| 112 | Lymphopenia (HP:0001888) | 1.97680074 |
| 113 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.97526278 |
| 114 | Hepatosplenomegaly (HP:0001433) | 1.97427954 |
| 115 | Gingival bleeding (HP:0000225) | 1.96026327 |
| 116 | Premature loss of primary teeth (HP:0006323) | 1.94441676 |
| 117 | Encephalitis (HP:0002383) | 1.94005832 |
| 118 | B lymphocytopenia (HP:0010976) | 1.93338219 |
| 119 | Abnormality of B cell number (HP:0010975) | 1.93338219 |
| 120 | IgM deficiency (HP:0002850) | 1.93248450 |
| 121 | Prolonged bleeding time (HP:0003010) | 1.91460220 |
| 122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90012588 |
| 123 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90012588 |
| 124 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90012588 |
| 125 | Progressive visual loss (HP:0000529) | 1.88927119 |
| 126 | Papilloma (HP:0012740) | 1.88522852 |
| 127 | Verrucae (HP:0200043) | 1.88522852 |
| 128 | Poor head control (HP:0002421) | 1.86811734 |
| 129 | Abnormal platelet volume (HP:0011876) | 1.85576188 |
| 130 | Skin rash (HP:0000988) | 1.85055577 |
| 131 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.84632996 |
| 132 | Abnormality of T cell number (HP:0011839) | 1.84174783 |
| 133 | Anorexia (HP:0002039) | 1.83590844 |
| 134 | Epistaxis (HP:0000421) | 1.83324297 |
| 135 | Bone pain (HP:0002653) | 1.83157088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.01188386 |
| 2 | MAP3K14 | 3.90784492 |
| 3 | RIPK4 | 3.84475716 |
| 4 | IRAK4 | 3.55933031 |
| 5 | ERN1 | 2.89169958 |
| 6 | TBK1 | 2.69354187 |
| 7 | IRAK3 | 2.68396050 |
| 8 | MAP4K1 | 2.63130301 |
| 9 | TYK2 | 2.62087805 |
| 10 | PBK | 2.58716634 |
| 11 | MST4 | 2.55586204 |
| 12 | TNK2 | 2.29223802 |
| 13 | CSK | 2.10839790 |
| 14 | IKBKE | 2.05539169 |
| 15 | STK10 | 1.98718993 |
| 16 | MST1R | 1.93747136 |
| 17 | EPHB1 | 1.92904453 |
| 18 | MAP3K10 | 1.92041541 |
| 19 | CLK1 | 1.89367380 |
| 20 | TAOK1 | 1.82282561 |
| 21 | IKBKB | 1.81639129 |
| 22 | FGR | 1.75923075 |
| 23 | PIM2 | 1.69299164 |
| 24 | BMX | 1.60579228 |
| 25 | HCK | 1.53553839 |
| 26 | FES | 1.51403596 |
| 27 | TXK | 1.49124030 |
| 28 | JAK1 | 1.48845038 |
| 29 | BTK | 1.45028514 |
| 30 | JAK3 | 1.41503502 |
| 31 | GRK6 | 1.40848541 |
| 32 | PRPF4B | 1.39884818 |
| 33 | TEC | 1.33051131 |
| 34 | SYK | 1.32975404 |
| 35 | TRPM7 | 1.30706016 |
| 36 | KIT | 1.29681612 |
| 37 | PIM1 | 1.27484277 |
| 38 | TGFBR2 | 1.27390530 |
| 39 | NEK9 | 1.23792827 |
| 40 | MATK | 1.22085738 |
| 41 | LYN | 1.21338718 |
| 42 | STK4 | 1.20004864 |
| 43 | CDK19 | 1.19881448 |
| 44 | RIPK1 | 1.18099987 |
| 45 | SIK2 | 1.14911110 |
| 46 | TAOK3 | 1.11640117 |
| 47 | ZAP70 | 1.09100099 |
| 48 | BMPR2 | 1.07015793 |
| 49 | FRK | 1.04538351 |
| 50 | CSF1R | 1.02765558 |
| 51 | IRAK2 | 1.01059562 |
| 52 | CHUK | 0.99973395 |
| 53 | PIK3CG | 0.98605894 |
| 54 | MARK3 | 0.97961663 |
| 55 | PRKD2 | 0.97936272 |
| 56 | MAP3K6 | 0.97657848 |
| 57 | MAP3K13 | 0.95842078 |
| 58 | TAOK2 | 0.94233661 |
| 59 | LCK | 0.91986837 |
| 60 | EPHA2 | 0.91275487 |
| 61 | PTK2B | 0.90259739 |
| 62 | LRRK2 | 0.88359382 |
| 63 | PTK6 | 0.84358050 |
| 64 | GRK7 | 0.83549410 |
| 65 | JAK2 | 0.79035532 |
| 66 | ABL2 | 0.75573477 |
| 67 | DAPK2 | 0.73827091 |
| 68 | ADRBK2 | 0.73439533 |
| 69 | YES1 | 0.72244442 |
| 70 | TESK2 | 0.71605230 |
| 71 | PRKCD | 0.70848913 |
| 72 | ABL1 | 0.69431830 |
| 73 | KSR2 | 0.68659189 |
| 74 | MAP2K4 | 0.67758783 |
| 75 | STK3 | 0.67718720 |
| 76 | FGFR3 | 0.67123555 |
| 77 | ERBB3 | 0.65378292 |
| 78 | PDPK1 | 0.65219422 |
| 79 | PRKG2 | 0.64411140 |
| 80 | EGFR | 0.62133624 |
| 81 | EIF2AK2 | 0.61261427 |
| 82 | MAPK7 | 0.60475912 |
| 83 | MAP2K6 | 0.60283612 |
| 84 | CAMKK2 | 0.59886256 |
| 85 | MARK2 | 0.59449236 |
| 86 | RPS6KA4 | 0.57936419 |
| 87 | EPHA3 | 0.54674859 |
| 88 | ACVR1B | 0.53782173 |
| 89 | ITK | 0.51915942 |
| 90 | PRKCQ | 0.49570039 |
| 91 | TIE1 | 0.48005277 |
| 92 | MAP3K7 | 0.47890251 |
| 93 | MAPKAPK2 | 0.46888236 |
| 94 | BCKDK | 0.45703937 |
| 95 | DYRK1B | 0.45668143 |
| 96 | MAP3K3 | 0.44596581 |
| 97 | FGFR4 | 0.43971604 |
| 98 | NUAK1 | 0.43835825 |
| 99 | ADRBK1 | 0.43119212 |
| 100 | KDR | 0.42790602 |
| 101 | NLK | 0.42665254 |
| 102 | FYN | 0.41764028 |
| 103 | IRAK1 | 0.39875567 |
| 104 | MAP3K12 | 0.39134381 |
| 105 | NME2 | 0.39030995 |
| 106 | CDK6 | 0.38421413 |
| 107 | STK11 | 0.38085005 |
| 108 | MAP3K11 | 0.37934249 |
| 109 | SIK3 | 0.37407320 |
| 110 | MAPK4 | 0.37272462 |
| 111 | MAP2K3 | 0.36622597 |
| 112 | CDC42BPA | 0.36103688 |
| 113 | MAP3K5 | 0.35286172 |
| 114 | STK38 | 0.34990300 |
| 115 | PAK4 | 0.34822356 |
| 116 | RPS6KA6 | 0.32988141 |
| 117 | MAP3K2 | 0.32397864 |
| 118 | HIPK2 | 0.31026624 |
| 119 | PINK1 | 0.30528702 |
| 120 | MAP3K1 | 0.30240663 |
| 121 | MAP2K2 | 0.29180729 |
| 122 | DYRK3 | 0.29022642 |
| 123 | PDK1 | 0.26929315 |
| 124 | RPS6KL1 | 0.26244535 |
| 125 | RPS6KC1 | 0.26244535 |
| 126 | ZAK | 0.25732310 |
| 127 | CAMK1D | 0.25713838 |
| 128 | PRKD1 | 0.24824173 |
| 129 | STK24 | 0.24147165 |
| 130 | TTN | 0.24042541 |
| 131 | MAPK12 | 0.23871261 |
| 132 | PRKCH | 0.23177233 |
| 133 | GRK1 | 0.22846830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.36978616 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.29846398 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.52454145 |
| 4 | Pertussis_Homo sapiens_hsa05133 | 2.35402445 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.34049011 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.31654859 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.29913708 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.23765469 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.18652928 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.14808768 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.13335759 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.11049000 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.03140268 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.02149948 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.91344747 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.85498794 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 1.84777667 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.79433443 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.78562936 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.77404926 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75624675 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69577262 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 1.68706645 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.68047972 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.66838432 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.66388254 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.53734835 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51684940 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49605113 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.47374373 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.47321628 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.46556255 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46158843 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.45787903 |
| 35 | Mineral absorption_Homo sapiens_hsa04978 | 1.44830779 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.44244163 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43939674 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.41320655 |
| 39 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.34600309 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.32492758 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.31249489 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30899147 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28059701 |
| 44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.22292771 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.09738789 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.06832425 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.06388840 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05684441 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04271516 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.01547973 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.01026075 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.98955537 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.98502381 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96193376 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91228821 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88566587 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85541104 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81997784 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.81275418 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79952246 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79806597 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.79797719 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76524090 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70262745 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66222827 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63672130 |
| 67 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61837613 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61345554 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60953351 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58439461 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57871397 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56532358 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56188454 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55921425 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53198735 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52880479 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49247326 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48958482 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48558759 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48539951 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48129522 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47424294 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47397330 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46573331 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45722722 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43058842 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40572977 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40235792 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39425615 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36232089 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36162359 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36058799 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35728049 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35715493 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35585892 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.35388389 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35361780 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34943075 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.33879448 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33318226 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32315825 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31983621 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31918891 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.31903626 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31733907 |
| 106 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.31102596 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30724991 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30664110 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.28618890 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27696352 |
| 111 | Adherens junction_Homo sapiens_hsa04520 | 0.25716880 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23615926 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23179134 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23117797 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22869793 |
| 116 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.22419677 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.21834822 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.21698567 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21621368 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20668080 |

